Research programme: membrane active metal ion chelators - D-Pharm
Alternative Names: DP-109; DP-460Latest Information Update: 04 Nov 2017
At a glance
- Originator D-Pharm
- Class Antidementias; Antimalarials; Antiprotozoals; Small molecules
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported African trypanosomiasis; Alzheimer's disease; Malaria
- Discontinued Amyotrophic lateral sclerosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in African trypanosomiasis in Israel
- 04 Nov 2017 No recent reports of development identified for preclinical development in Alzheimer's-disease in Israel (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Malaria in Israel